FDA Backs Proposed Stem Cell Trial for Treatment-Resistant Crohn’s Disease
StemSmart Crohn’s disease clinical trial gets positive FDA pre-IND feedback on 6 of 7 questions; a viral safety issue remains. Not a marketing approval.
StemSmart Crohn’s disease clinical trial gets positive FDA pre-IND feedback on 6 of 7 questions; a viral safety issue remains. Not a marketing approval.